Searchable abstracts of presentations at key conferences in endocrinology

ea0016p36 | Adrenal | ECE2008

Aberrant cortisol responses in adrenal incidentalomas: a study on evaluation and management of 20 patients

Priou Melanie , Busson Catherine Draunet , Illouz Frederic , Hamy Antoine , Schinkel Elsa Parot , Rodien Patrice , Rohmer Vincent

In overt or subclinical ACTH-independant Cushing’s syndrome (CS), aberrant adrenal receptors may control cortisol secretion.We systematically studied the 20 patients with adrenal incidentaloma screened in our department for illegitimate adrenal receptors between 2000 and 2006. We investigated plasma cortisol level during successive stimulation tests performed while dexamethasone was given orally every 8 h (upright posture, meal, hypothalamic hormone...

ea0063oc4.4 | Thyroid 1 | ECE2019

Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France

Sibilia Paul , Briet Claire , Prunier-Mirebeau Delphine , Moal Valerie , Bouhours-Nouet Natacha , Coutant Regis , Rodien Patrice , Illouz Frederic

Introduction: The syndrome of reduced sensitivity to thyroid hormone (SRSTH) due to mutations of thyroid hormone receptor β (TRB) consists of an inappropriate secretion of TSH with elevated levels of thyroid hormones. Cardiovascular manifestations are often the ones that affect patients. Our aim was to evaluate the cardiac and vascular characteristics of patients with SRSTH due to TRB mutations.Materials and methods: We analysed cl...

ea0073yi5 | Young Investigator Awards | ECE2021

Atlas of G protein-coupled receptors in radioiodine-refractory thyroid cancer: Novel therapeutic targets for drug repositioning?

Suteau Valentine , Valérie Seegers , Munier Mathilde , Boubaker Rym Ben , Illouz Frederic , Ghamrawi Sarah , Briet Marie , Rodien Patrice , Briet Claire

IntroductionProgressive and radioiodine-refractory thyroid cancer has poor outcomes and limited therapeutic options (i.e tyrosine kinase inhibitors) due to the transient efficacy of treatment and toxic effects. Therefore, combinatorial treatment with new therapeutic approaches are needed. Many studies link G Protein-Coupled Receptors (GPCRs) to cancer. The aim of this study is to present the first specific atlas of GPCRs expression in progressive and ref...

ea0090p369 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the Cranioexe randomized placebo-controlled trial

Gatta-Cherifi Blandine , Mohammedi Kamel , Cariou Tanguy , Poitou-Bernert Christine , Touraine Philippe , Raverot Gerald , Brue Thierry , Chanson Philippe , Illouz Frederic , Solange Grunenwald , Chabre Olivier , Sonnet Emmanuel , Cuny Thomas , Bertherat Jerome , Czernichow Sebastien , Frison Eric , Tabarin Antoine

Background: Hyperphagia leading to craniopharyngioma-related obesity (CRO) is a common and serious sequel of treatments of craniopharyngiomas. The few therapeutic approaches that have been tested until now for the control of eating behaviour and weight have poor efficacy. Glucagon-like peptide-1 (GLP-1) analogues might be an option. Methods: This multicentre, randomised, double-blind superiority trial was conducted in France. Adults with CRO (BMI > 3...